BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28315398)

  • 1. Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.
    Dai E; Zhang L; Ye L; Wan S; Feng L; Qi Q; Yao F; Li Z
    Int J Infect Dis; 2017 Jun; 59():124-130. PubMed ID: 28315398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
    Julien B; Grenard P; Teixeira-Clerc F; Van Nhieu JT; Li L; Karsak M; Zimmer A; Mallat A; Lotersztajn S
    Gastroenterology; 2005 Mar; 128(3):742-55. PubMed ID: 15765409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Hezode C; Mallat A; Lotersztajn S
    Pathol Biol (Paris); 2008 Feb; 56(1):36-8. PubMed ID: 17412522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Li L; Serriere-Lanneau V; Ledent C; Mallat A; Lotersztajn S
    Nat Med; 2006 Jun; 12(6):671-6. PubMed ID: 16715087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.
    Muñoz-Luque J; Ros J; Fernández-Varo G; Tugues S; Morales-Ruiz M; Alvarez CE; Friedman SL; Arroyo V; Jiménez W
    J Pharmacol Exp Ther; 2008 Feb; 324(2):475-83. PubMed ID: 18029545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cannabinoids in chronic liver diseases.
    Parfieniuk A; Flisiak R
    World J Gastroenterol; 2008 Oct; 14(40):6109-14. PubMed ID: 18985799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
    Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
    Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
    Giannone FA; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P
    Lab Invest; 2012 Mar; 92(3):384-95. PubMed ID: 22184091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury.
    Wang L; Yang L; Tian L; Mai P; Jia S; Yang L; Li L
    J Cell Physiol; 2017 Jan; 232(1):110-21. PubMed ID: 27028843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
    Kim SD; Cho KJ; Kim JC
    BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
    Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
    J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.
    Zurolo E; Iyer AM; Spliet WG; Van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 Sep; 170(1):28-41. PubMed ID: 20621164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the endocannabinoid receptors in human fascial tissue.
    Fede C; Albertin G; Petrelli L; Sfriso MM; Biz C; De Caro R; Stecco C
    Eur J Histochem; 2016 Jun; 60(2):2643. PubMed ID: 27349320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
    Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
    Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local Pathophysiology.
    Konermann A; Jäger A; Held SAE; Brossart P; Schmöle A
    Cell Mol Neurobiol; 2017 Nov; 37(8):1511-1520. PubMed ID: 28289947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis.
    Floreani A; Lazzari R; Macchi V; Porzionato A; Variola A; Colavito D; Leon A; Guido M; Baldo V; De Caro R; Bergasa NV
    J Gastroenterol; 2010; 45(1):68-76. PubMed ID: 19730968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.
    Suk KT; Mederacke I; Gwak GY; Cho SW; Adeyemi A; Friedman R; Schwabe RF
    Gut; 2016 Oct; 65(10):1721-32. PubMed ID: 27196571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.